Latest News
Latest market news and analysis across US stocks, Hong Kong equities, crypto, derivatives, gold and oil.
News List
Hang Seng Plunges 2% as Tencent and Alibaba Lead Tech Rout; Market Sentiment Sours, Funds Rotate to Defensives
Hong Kong's Hang Seng Index tumbled over 2% on Monday, with tech heavyweights Tencent and Alibaba leading the decline amid renewed regulatory and external policy concerns. Investors shifted into defensive sectors like utilities and telecoms, signaling a cautious turn in market sentiment.
Circle and Nomura join forces to target a $440 billion daily foreign exchange market in Japan
The stablecoin giant and the Japanese financial corporation plan to deploy cross-border foreign exchange settlements as early as next year.
White River Bancshares Declares $0.50 Quarterly Dividend, Sustaining Steady Shareholder Returns
White River Bancshares Co. (WRIV) announces a $0.50 per share quarterly cash dividend, maintaining its consistent payout policy with an annualized yield of approximately 2.8%. The company has paid dividends for 10 consecutive quarters, reflecting solid financial health and commitment to investor returns.
Gold and Oil Divergence: How Safe-Haven and Demand Dynamics Shape Derivatives Markets
This article analyzes the recent divergence between gold's rally on safe-haven demand and crude oil's decline on weak demand, exploring geopolitical and economic impacts on commodity derivatives and offering trading strategies.
Tencent and Alibaba Lead Rally, Hang Seng Index Reclaims 20,000 Points: Analysis of Hong Kong Stock Rebound Drivers
The Hang Seng Index surged back above the 20,000-point mark today, driven by heavyweight stocks Tencent and Alibaba. This article analyzes the factors behind the tech sector rally, shifts in market sentiment and capital flows, and key outlook points.
Bitcoin (BTC) derivatives signal price panic. A weak U.S. inflation reading could trigger snapback: Crypto Daily
Your day-ahead look for June 25, 2026
TTM Technologies Surges 3.5% After Joining Russell 1000 Index
TTM Technologies (TTMI) was officially added to the Russell 1000 Index, driving its stock up approximately 3.5%. This article explores the significance of the index inclusion, the company's fundamentals, and future outlook, covering PCB industry trends and key investment points.
Gold Futures Break All-Time High Amid Middle East Tensions and Rate Cut Expectations: What's Next?
Analyzing the dual drivers of Middle East geopolitical conflict and Fed rate cut expectations that pushed gold futures above $2,400 per ounce, and looking ahead at key variables and investment opportunities.
Hang Seng Hits Yearly High: Tencent and Alibaba Lead Tech Rally - Key Drivers
The Hang Seng Index hits a new yearly high, driven by strong earnings from Tencent and Alibaba and policy support. This article analyzes the tech rebound, macro improvements, and market outlook.
Bitcoin supply in loss hits an all-time high as long term holders remain unfazed
Almost 11 million bitcoin are now held at a loss, while long-term holders control a record 14.8 million coins.
Nuvation Bio Issues $200M Convertible Senior Notes: Financing Details and Market Impact Analysis
Nuvation Bio announces a $200M private placement of convertible senior notes to advance oncology drug development. This article analyzes the financing terms, company fundamentals, and market reaction, exploring potential impacts on stock price and pipeline.
Hong Kong's Hang Seng Index Falls Below 21,000 Points, Tech Stocks Plunge: Tencent and Alibaba Lead Decline, Market Sentiment Turns Cautious
Hong Kong's Hang Seng Index fell below the 21,000-point mark today, with tech stocks taking a collective hit as heavyweights like Tencent and Alibaba led the decline. Analysts attribute the downturn to a combination of domestic and external factors, urging investors to monitor policy changes and economic data for future direction.
Forget max pain. Bitcoin is well below the $72,000 magnet going into $10 billion options expiry
The popular max pain theory isn’t working out as bitcoin trades far from the $72K level a day ahead of a $10 billion quarterly options settlement.
Acuity Earnings Beat: Non-GAAP EPS of $5.31 and Revenue of $1.2 Billion Surpass Expectations
Acuity's latest quarterly results exceeded analyst forecasts with Non-GAAP EPS of $5.31 and revenue of $1.2 billion. Analysts raise price targets as the company offers a positive outlook.
Copper Prices Retreat from Record Highs: Derivatives Market Outlook Amid Supply-Demand Gap
Copper futures surged to record highs before retreating, as global mine supply constraints clash with rising demand from the green energy transition. This article explores key drivers for copper prices from a derivatives perspective, assessing whether the supply deficit can sustain elevated levels.
Tencent and Alibaba Lead Hang Seng Rally: Hong Kong Tech Stocks Stage a Strong Comeback
A recent surge in Hong Kong's tech stocks, led by Tencent and Alibaba, signals a robust recovery driven by capital inflows, policy support, and valuation repairs. This analysis explores the market dynamics and outlook.
Biggest stock movers Thursday: AI chip stocks, WEN, HTZ, and more (MU:NASDAQ)
U.S. stock futures rise on Micron earnings beat as markets await May inflation data.
Gold Futures Positions Surge as Risk Aversion Drives Short-Term Price Analysis
An in-depth analysis of gold futures positioning data, combined with geopolitical tensions, explores capital flows and short-term gold price trends. CFTC data shows net long positions rising, with safe-haven funds pouring into gold derivatives.
Hang Seng Index Breaches 19,000 Mark as Tech Stocks Lead Decline; Market Sentiment Sours
The Hang Seng Index fell below the psychological support level of 19,000 points, with tech stocks broadly declining. This article analyzes the reasons behind the drop in heavyweight stocks like Tencent and Alibaba, and examines macroeconomic factors and capital flow disruptions.
Ionis Licenses Zilganerse to Recordati Outside U.S. in Biotech Deal
Ionis Pharmaceuticals has signed an exclusive licensing agreement with Recordati for its rare disease drug Zilganerse, covering markets outside the United States. The deal highlights strategic risk-sharing and commercial expansion in the biopharma sector.